Drug Delivery and Glaucoma: Dextenza for Xen Patients

Show Description +

I. Paul Singh, MD, shares an example of one patient of a case series of 10 patients in which he has placed a Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) in the inferior and superior canaliculus for patients after Xen Gel Stent (Allergan) implantation.

Posted: 10/10/2022

Drug Delivery and Glaucoma: Dextenza for Xen Patients

I. Paul Singh, MD, shares an example of one patient of a case series of 10 patients in which he has placed a Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) in the inferior and superior canaliculus for patients after Xen Gel Stent (Allergan) implantation.

Posted: 10/10/2022

Please log in to leave a comment.

More in Glaucoma

Progressing at Normal Pressures: A Case for the OPAP

John P. Berdahl, MD; Natalia Morales, MD; Tanner J. Ferguson, MD; and Justin Schweitzer, OD, FAAO

The Road Ahead in Glaucoma Treatment

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Jason Bacharach, MD

AquaLumen Technique

Rajen U. Desai, MD